Cargando…
Efficacy of hypophysectomy for the treatment of hypersomatotropism‐induced diabetes mellitus in 68 cats
BACKGROUND: Hypersomatotropism (HST) is an increasingly recognized endocrinopathy in cats and is mostly described associated with diabetes mellitus (DM). OBJECTIVES: To evaluate the efficacy and safety of transsphenoidal hypophysectomy in treating HST and DM in cats. ANIMALS: Sixty‐eight client‐owne...
Autores principales: | Fenn, Joe, Kenny, Patrick J., Scudder, Christopher J., Hazuchova, Katarina, Gostelow, Ruth, Fowkes, Robert C., Forcada, Yaiza, Church, David B., Niessen, Stijn J. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995378/ https://www.ncbi.nlm.nih.gov/pubmed/33624865 http://dx.doi.org/10.1111/jvim.16080 |
Ejemplares similares
-
Pasireotide Long‐Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism
por: Gostelow, R., et al.
Publicado: (2017) -
Pasireotide for the Medical Management of Feline Hypersomatotropism
por: Scudder, C.J., et al.
Publicado: (2015) -
Evaluation of hypophysectomy for treatment of hypersomatotropism in 25 cats
por: van Bokhorst, Kirsten L., et al.
Publicado: (2021) -
Hypersomatotropism in 3 Cats without Concurrent Diabetes Mellitus
por: Fletcher, J.M., et al.
Publicado: (2016) -
Serum N‐Terminal Type III Procollagen Propeptide: An Indicator of Growth Hormone Excess and Response to Treatment in Feline Hypersomatotropism
por: Keyte, S.V., et al.
Publicado: (2016)